Gene:
KLK5
kallikrein-related peptidase 5

PharmGKB contains no prescribing info for this . Contact us to report known genotype-based dosing guidelines, or if you are interested in developing guidelines.

PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

Overview

Alternate Names:  None
Alternate Symbols:  KLK-L2; SCTE
PharmGKB Accession Id: PA30155

Details

Cytogenetic Location: chr19 : q13.33 - q13.41
GP mRNA Boundary: chr19 : 51446559 - 51456344
GP Gene Boundary: chr19 : 51443559 - 51466344
Strand: minus

Visualization

UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.

View on UCSC Browser
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

LinkOuts

NCBI Gene:
25818
OMIM:
605643
UCSC Genome Browser:
NM_012427
RefSeq RNA:
NM_001077491
NM_001077492
NM_012427
RefSeq Protein:
NP_001070959
NP_001070960
NP_036559
RefSeq DNA:
NT_011109
UniProtKB:
Q53ZR3_HUMAN (Q53ZR3)
KLK5_HUMAN (Q9Y337)
Ensembl:
ENSG00000167754
GenAtlas:
KLK5
GeneCard:
KLK5
MutDB:
KLK5
ALFRED:
LO000483P
HuGE:
KLK5
Comparative Toxicogenomics Database:
25818
ModBase:
Q9Y337
HumanCyc Gene:
HS09623
HGNC:
6366

Common Searches